Anna is Co-founder and Managing Director of SeeingTheta Strategic Consulting, which specialises in COA, regulatory and payer strategy. A neuroscientist by training, she has always been fascinated by a simple but staggering fact: that a kilo and a half of soft tissue in our heads makes us who we are, behind every thought, feeling, decision and relationship. That fascination took her to a Wellcome Trust-funded PhD at University College London.
Always drawn to business, Anna co-founded a start-up during her PhD, and went on to apply her academic thinking to real-world problems. She spent a decade in patient-centred science and clinical outcome assessment at a large global CRO and consulting company, driven throughout by the story behind the numbers.
Anna is also an informal caregiver. She sees the healthcare system from the patient’s side, including the moments when someone’s experience doesn’t fit the boxes on the form. Elevating the patient voice is a professional commitment for her, and a personal one too.
Anna has worked with a wide range of pharmaceutical and biotech companies and their cross-functional teams, across therapy areas and with CNS as a particular strength. She has supported interactions with the FDA and EMA and built evidence strategies for payers, giving her a view of what a product needs across its whole life cycle. At SeeingTheta, she is a thought partner to leadership teams: naming the real challenge, choosing an approach and weighing its trade-offs, then agreeing practical next steps that fit the team’s strategic objectives and timelines.
As a child, Anna wanted to be a dentist. At SeeingTheta, she still gets her teeth into things, only now they’re the hard nuts clients bring when a problem is tougher than it first looks.